OTC Pharmaceuticals in Sweden

Product Code DAT02666
Publication Date November 2010
Publisher Datamonitor
Product Type Report
Pages 44
ISBN Number not applicable

OTC Pharmaceuticals in Sweden

Datamonitor's OTC Pharmaceuticals in Sweden industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

  • Contains an executive summary and data on value, volume and/or segmentation
  • Provides textual analysis of OTC Pharmaceuticals in Sweden's recent performance and future prospects
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Includes a five-year forecast of OTC Pharmaceuticals in Sweden
  • The leading companies are profiled with supporting key financial metrics
  • Supported by the key macroeconomic and demographic data affecting the market

Highlights

  • Detailed information is included on market size, measured by both value and volume
  • Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
  • Market shares are covered by manufacturer and/or brand
  • Also features market breakdown by distribution channel

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purpose of this report Europe comprises Belgium, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Ukraine and the United Kingdom.

Contents

  • Executive Summary
  • Market Overview
    • Market Definition
    • Research Highlights
    • Market Analysis
  • Market Value
  • Market Segmentation I
  • Market Segmentation II
  • Market Share
  • Five Forces Analysis
    • Summary
    • Buyer Power
    • Supplier Power
    • New Entrants
    • Substitutes
    • Rivalry
  • Leading Companies
    • Johnson & Johnson
    • Novartis Ag
    • Bayer Ag
  • Market Distribution
  • Market Forecasts
    • Market Value Forecast
  • Macroeconomic Indicators
  • Appendix
    • Methodology
    • Industry Associations
    • Related Datamonitor Research
    • Disclaimer
  • About Datamonitor
    • Premium Reports
    • Summary Reports
    • Datamonitor Consulting
  • List of Tables
    • Table 1: Sweden Otc Pharmaceuticals Market Value: $ Million, 2005-09
    • Table 2: Sweden Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
    • Table 3: Sweden Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
    • Table 4: Sweden Otc Pharmaceuticals Market Share: % Share, by Value, 2009
    • Table 5: Johnson & Johnson: Key Facts
    • Table 6: Johnson & Johnson: Key Financials ($)
    • Table 7: Johnson & Johnson: Key Financial Ratios
    • Table 8: Novartis Ag: Key Facts
    • Table 9: Novartis Ag: Key Financials ($)
    • Table 10: Novartis Ag: Key Financial Ratios
    • Table 11: Bayer Ag: Key Facts
    • Table 12: Bayer Ag: Key Financials ($)
    • Table 13: Bayer Ag: Key Financials (€)
    • Table 14: Bayer Ag: Key Financial Ratios
    • Table 15: Sweden Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
    • Table 16: Sweden Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14
    • Table 17: Sweden Size of Population (Million), 2005-09
    • Table 18: Sweden Gdp (Constant 2000 Prices, $ Billion), 2005-09
    • Table 19: Sweden Gdp (Current Prices, $ Billion), 2005-09
    • Table 20: Sweden Inflation, 2005-09
    • Table 21: Sweden Consumer Price Index (Absolute), 2005-09
    • Table 22: Sweden Exchange Rate, 2005-09
  • List of Figures
    • Figure 1: Sweden Otc Pharmaceuticals Market Value: $ Million, 2005-09
    • Figure 2: Sweden Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
    • Figure 3: Sweden Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
    • Figure 4: Sweden Otc Pharmaceuticals Market Share: % Share, by Value, 2009
    • Figure 5: Forces Driving Competition in The Otc Pharmaceuticals Market in Sweden, 2009
    • Figure 6: Drivers of Buyer Power in The Otc Pharmaceuticals Market in Sweden, 2009
    • Figure 7: Drivers of Supplier Power in The Otc Pharmaceuticals Market in Sweden, 2009
    • Figure 8: Factors Influencing The Likelihood of New Entrants in The Otc Pharmaceuticals Market in Sweden, 2009
    • Figure 9: Factors Influencing The Threat of Substitutes in The Otc Pharmaceuticals Market in Sweden, 2009
    • Figure 10: Drivers of Degree of Rivalry in The Otc Pharmaceuticals Market in Sweden, 2009
    • Figure 11: Johnson & Johnson: Revenues & Profitability
    • Figure 12: Johnson & Johnson: Assets & Liabilities
    • Figure 13: Novartis Ag: Revenues & Profitability
    • Figure 14: Novartis Ag: Assets & Liabilities
    • Figure 15: Bayer Ag: Revenues & Profitability
    • Figure 16: Bayer Ag: Assets & Liabilities
    • Figure 17: Sweden Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
    • Figure 18: Sweden Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14